(XEMD) Xtrackers MSCI Emerging - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE000GWA2J58 • Global Emerging Markets Equity

XEMD: Stocks, Bonds, Emerging Markets, Securities

Xtrackers MSCI Emerging Markets UCITS ETF 1D (XETRA:XEMD) is a Ireland-domiciled ETF designed for investors seeking exposure to emerging markets equities. Listed on the XETRA exchange, this fund tracks the Morningstar EM Total Return Net USD Index, offering a diversified portfolio of stocks across various emerging economies.

With an AUM of 5.417 billion EUR, this ETF is a sizable fund, indicating strong investor interest and liquidity. Its expense ratio is competitive, making it a cost-effective option for those looking to gain broad exposure to emerging markets without the need for direct stock selection.

As a UCITS-compliant ETF, it adheres to strict European regulations, providing investors with a level of transparency and regulatory security. This structure is particularly appealing to institutional investors and fund managers who prioritize compliance and stability in their portfolios.

The funds focus on emerging markets positions it as a vehicle for growth, given the long-term potential of these economies. However, it also comes with higher volatility and risks associated with geopolitical and economic uncertainties in these regions.

For fund managers and investors, this ETF offers the benefits of diversification, liquidity, and a rules-based approach to tracking its underlying index. It is a practical tool for those looking to allocate a portion of their portfolio to emerging markets while managing costs and operational complexity.

Additional Sources for XEMD ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

XEMD ETF Overview

Market Cap in USD 5,870m
Category Global Emerging Markets Equity
TER 0.18%
IPO / Inception 2021-11-03

XEMD ETF Ratings

Growth 5y 23.7%
Fundamental -
Dividend 47.3%
Rel. Strength Industry -13.4
Analysts -
Fair Price Momentum 6.71 EUR
Fair Price DCF -

XEMD Dividends

Dividend Yield 12m 2.28%
Yield on Cost 5y 2.28%
Annual Growth 5y 8.74%
Payout Consistency 96.9%

XEMD Growth Ratios

Growth Correlation 3m 25%
Growth Correlation 12m 81%
Growth Correlation 5y 32%
CAGR 5y 0.24%
CAGR/Max DD 5y 0.01
Sharpe Ratio 12m 0.94
Alpha 2.34
Beta 0.65
Volatility 16.85%
Current Volume 32.2k
Average Volume 20d 10.5k
What is the price of XEMD stocks?
As of March 14, 2025, the stock is trading at EUR 7.17 with a total of 32,176 shares traded.
Over the past week, the price has changed by -1.40%, over one month by -4.18%, over three months by -2.78% and over the past year by +8.80%.
Is Xtrackers MSCI Emerging a good stock to buy?
Neither. Based on ValueRay Analyses, Xtrackers MSCI Emerging is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 23.65 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XEMD as of March 2025 is 6.71. This means that XEMD is currently overvalued and has a potential downside of -6.42%.
Is XEMD a buy, sell or hold?
Xtrackers MSCI Emerging has no consensus analysts rating.
What are the forecast for XEMD stock price target?
According to ValueRays Forecast Model, XEMD Xtrackers MSCI Emerging will be worth about 7.4 in March 2026. The stock is currently trading at 7.17. This means that the stock has a potential upside of +3.77%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 7.4 3.8%